Biotech Cos. Rise as Gov\'t OKs New Stem Cell Lines

Contact
Colly Mitchell
Parker H. Petit Institute for Bioengineering and Bioscience
Contact Colly Mitchell
404-894-5982
Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

Biotech Cos. Rise as Gov't OKs New Stem Cell Lines

Full Summary:

Shares of companies developing stem cell therapies surged Wednesday on news that the federal government has cleared 13 new stem cell lines for testing, bringing to a close nearly a decade of restrictions.

By MATTHEW PERRONE - The Associated Press

WASHINGTON — Shares of companies developing stem cell therapies surged Wednesday on news that the federal government has cleared 13 new stem cell lines for testing, bringing to a close nearly a decade of restrictions.

"For the first time all these programs that have been held in check by the closed stem cell policy can move forward," said Steve Brozak, president and analyst with WBB Securities, an investment brokerage focused on drug and biotech companies.

Read full article

Additional Information

Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Categories
Institute and Campus, Economic Development and Policy, Cancer Research, Research
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
biotech companies, embryonic stem cells, IBB, Stem Cell Research
Status
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Dec 3, 2009 - 8:00pm
  • Last Updated: Oct 7, 2016 - 11:06pm